Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method to treat using antagonistic anti-hTNFSF13b human antibodies

Method to treat using antagonistic anti-hTNFSF13b human antibodies

US Patent 8173124 · Granted May 8, 2012

Estimated economic value: $70,486,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

PAN-ELR+ CXC chemokine antibodies for the treatment of hidradenitis suppurativa2024
Anti-CD11D antibodies and uses thereof2024
Pan-ELR+ CXC chemokine antibodies2020
Pan-ELR+ CXC chemokine antibodies2018
Anti-CD20− / anti-BAFF bispecific antibodies2018
Pan-ELR+ CXC chemokine antibodies2017
Nucleic acids encoding antibodies that bind IL-232017
Pan-ELR+ CXC Chemokine Antibodies2016
Antibodies that bind to IL-232015
Sialoadhesin factor-2 antibodies2012
Methods of use of sialoadhesin factor-2 antibodies2012
Methods of use of sialoadhesin factor-2 antibodies2011